The role of modeling and simulation to improve the treatment of fungal infections caused by Cryptococcus : A literature review

The role of modeling and simulation to improve the treatment of fungal infections caused by Cryptococcus : A literature review

Bibliographic Details
Main Authors:	Keli Jaqueline Staudt, Laura Ben Olivo, Izabel Almeida Alves, Bibiana Verlindo de Araújo
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2024-04-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Antifungals Cryptococcosis Mathematical modeling Pharmacodynamics Pharmacokinetics
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502024000100315&tlng=en

Similar Items

Precision Therapy for Invasive Fungal Diseases
by: Anne-Grete Märtson, et al.
Published: (2021-12-01)

Allicin shows antifungal efficacy against Cryptococcus neoformans by blocking the fungal cell membrane
by: Zhun Li, et al.
Published: (2022-11-01)

Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System
by: Keli Jaqueline Staudt, et al.
Published: (2023-06-01)

The influence of sepsis on antimicrobials tissue penetration: The use of microdialysis technique to access free drug distribution
by: Karolina Torres Santos-Borges, et al.
Published: (2023-11-01)

<i>Cryptococcus neoformans</i> Causing Meningoencephalitis in Adults and a Child from Lima, Peru: Genotypic Diversity and Antifungal Susceptibility
by: Carolina Firacative, et al.
Published: (2022-12-01)

Assessment of Antifungal Pharmacodynamics
by: Alex Howard, et al.
Published: (2023-02-01)

Meningoencephalomyelitis and pneumonia caused by Cryptococcus spp. in a cat - case report
by: A.S. Siviero, et al.
Published: (2023-09-01)

Adrenocortical insufficiency caused by Cryptococcus neoformans: a case report and literature review
by: LIU Hongwei, et al.
Published: (2023-05-01)

Primary Cutaneous Cryptococcosis Caused by <i>Cryptococcus gatti</i> in an Elderly Patient
by: Walter Belda, et al.
Published: (2022-08-01)

Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
by: Kyle McEvoy, et al.
Published: (2020-08-01)

<i>Cryptococcus neoformans</i> and <i>Cryptococcus gattii</i> Species Complexes in Latin America: A Map of Molecular Types, Genotypic Diversity, and Antifungal Susceptibility as Reported by the Latin American Cryptococcal Study Group
by: Carolina Firacative, et al.
Published: (2021-04-01)

Pulmonary Cryptococcosis
by: Annaleise R. Howard-Jones, et al.
Published: (2022-10-01)

Infections due to Rare <i>Cryptococcus</i> Species. A Literature Review
by: Soraya E. Morales-López, et al.
Published: (2021-04-01)

Therapeutic Drug Monitoring of Antimicrobials in Critically Ill Obese Patients
by: Julie Gorham, et al.
Published: (2023-06-01)

<i>Cryptococcus neoformans</i> VNII as the Main Cause of Cryptococcosis in Domestic Cats from Rio de Janeiro, Brazil
by: Rosani Santos Reis, et al.
Published: (2021-11-01)

Cryptococcus in Wildlife and Free-Living Mammals
by: Patrizia Danesi, et al.
Published: (2021-01-01)

The war on cryptococcosis: A Review of the antifungal arsenal
by: Ahmad Mourad, et al.
Published: (2018-02-01)

Editorial: Immune interactions with pathogenic and commensal fungi
by: Wenjie Fang, et al.
Published: (2023-01-01)

Pulmonary Pharmacokinetic and Pharmacodynamic Evaluation of Ampicillin/Sulbactam Regimens for Pneumonia Caused by Various Bacteria, including <i>Acinetobacter baumannii</i>
by: Tetsushu Onita, et al.
Published: (2023-02-01)

Pharmacokinetic/pharmacodynamic comparison between generic and brand-name levofloxacin based on Monte Carlo simulation
by: Pan Ma, et al.
Published: (2023-06-01)

Distribution and association between environmental and clinical isolates of Cryptococcus neoformans in Bogotá-Colombia, 2012-2015
by: Norida Vélez, et al.

In Vitro Antifungal Activity of Chimeric Peptides Derived from Bovine Lactoferricin and Buforin II against <i>Cryptococcus neoformans</i> var. <i>grubii</i>
by: Silvia Katherine Carvajal, et al.
Published: (2022-12-01)

Cryptococcus and Cryptococcosis: Updates on Pathogenesis, Diagnosis and Treatment Strategies for HIV Infected Patients
by: Zainab Bandalizadeh, et al.
Published: (2018-08-01)

First isolation of Cryptococcus gattii molecular type VGII and Cryptococcus neoformans molecular type VNI from environmental sources in the city of Belém, Pará, Brazil
by: Solange do PSE Costa, et al.
Published: (2009-07-01)

Docetaxel Skin Exposure and Micronucleation Contributes to Skin Toxicity Caused by CPC634
by: Florence Atrafi, et al.
Published: (2021-07-01)

Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies
by: Ana Alarcia-Lacalle, et al.
Published: (2021-06-01)

The Influence of Extracorporeal Membrane Oxygenation on Antibiotic Pharmacokinetics
by: Gregory J. Peitz, et al.
Published: (2023-03-01)

Pharmacokinetic/Pharmacodynamic Model of Neutropenia in Real-Life Palbociclib-Treated Patients
by: Alexandre Le Marouille, et al.
Published: (2021-10-01)

Tigecycline Pharmacokinetic and Pharmacodynamic Profile in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
by: Maria Kipourou, et al.
Published: (2023-02-01)

Evaluation of vancomycin individualized model-based dosing approach in neonates
by: Manal Abouelkheir, et al.
Published: (2023-05-01)

A Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan
by: Yukihiro Hamada, et al.
Published: (2021-10-01)

Pulmonary Conventional Type 1 Langerin-Expressing Dendritic Cells Play a Role in Impairing Early Protective Immune Response against <i>Cryptococcus neoformans</i> Infection in Mice
by: Lorena Guasconi, et al.
Published: (2022-07-01)

Adaptive immunology of Cryptococcus neoformans infections—an update
by: Junsong Chen, et al.
Published: (2023-05-01)

Determination of the Pharmacokinetics and Pharmacodynamics of Isoniazid, Rifampicin, Pyrazinamide and Ethambutol in a Cross-Over Cynomolgus Macaque Model of <i>Mycobacterium tuberculosis</i> Infection
by: Laura Sibley, et al.
Published: (2022-11-01)

Phospholipase B Is Critical for Cryptococcus neoformans Survival in the Central Nervous System
by: Mohamed F. Hamed, et al.
Published: (2023-04-01)

Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
by: Giacomo Luci, et al.
Published: (2021-06-01)

Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia
by: Yvonne Schmiedel, et al.
Published: (2016-02-01)

Fast-acting insulin aspart: a review of its pharmacokinetic and pharmacodynamic properties and the clinical consequences
by: Hanne Haahr, et al.
Published: (2020-06-01)

COMPARISON OF PHARMACOKINETICS AND PHARMACODYNAMICS OF THE ORIGINAL AND GENERIC ENALAPRIL IN THE ELDERLY PATIENTS WITH ARTERIAL HYPERTENSION
by: O. P. Bobrova, et al.
Published: (2015-12-01)

Pharmacokinetics and antibacterial activity of tiamulin after single and multiple oral administrations in geese
by: Irene Sartini, et al.
Published: (2023-12-01)